AMY AXTELL: Open Payments
NPI 1821526179 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 42 payments from 8 companies in 2025. Trend: 2023 $1,486 · 2024 $846 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $334 |
| Neurocrine BioSciences, Inc. | 6 | $210 |
| Teva Pharmaceuticals USA, Inc. | 10 | $155 |
| Alkermes, Inc. | 4 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, INGREZZA, ARISTADA, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, UZEDY, COBENFY.
Industry payments across NY — which companies pay providers there.
